SD Biosensor, Inc. (KRX:137310)
8,690.00
-90.00 (-1.03%)
At close: Feb 6, 2026
SD Biosensor Revenue
SD Biosensor had revenue of 164.19B KRW in the quarter ending September 30, 2025, a decrease of -3.76%. This brings the company's revenue in the last twelve months to 696.13B, up 3.27% year-over-year. In the year 2024, SD Biosensor had annual revenue of 694.57B with 5.93% growth.
Revenue (ttm)
696.13B
Revenue Growth
+3.27%
P/S Ratio
1.49
Revenue / Employee
1.21B
Employees
576
Market Cap
1.04T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 694.57B | 38.90B | 5.93% |
| Dec 31, 2023 | 655.68B | -2,276.32B | -77.64% |
| Dec 31, 2022 | 2.93T | 2.04B | 0.07% |
| Dec 31, 2021 | 2.93T | 1.24T | 73.76% |
| Dec 31, 2020 | 1.69T | 1.61T | 2,211.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4.56T |
| Celltrion | 3.90T |
| Daewoong | 2.06T |
| Chong Kun Dang Pharmaceutical | 1.68T |
| Ildong Pharmaceutical | 575.66B |
| Seegene | 458.94B |
| Medy-Tox | 241.80B |
| Sam Chun Dang Pharm. | 220.74B |